Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 22-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 6 of 6)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
22-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala ALIMERA SCIENCES INC (ALIM) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala ALIMERA SCIENCES INC (ALIM) 12-months forecast 1 $15 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: ALIMERA SCIENCES -- ALIM 1 $11.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: ACRX , AKRX , ALIM , AOBI , AVNR , DYAX , SCLN , SCMP -- DRUGS 3 $34.50 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ALIM 11 $126.50 View Abstract

Independent Reports (Showing 1 to 6 of 6)

Release
Date Contributor Author Title Pages Price More Info
22-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-biomed/genetics 18 $207 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala ALIMERA SCIENCES INC (ALIM) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala ALIMERA SCIENCES INC (ALIM) 12-months forecast 1 $15 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: ALIMERA SCIENCES -- ALIM 1 $11.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: ACRX , AKRX , ALIM , AOBI , AVNR , DYAX , SCLN , SCMP -- DRUGS 3 $34.50 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for ALIM 11 $126.50 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.